Open Access
,
volume 14
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin
1, 2, 3, 4
,
Xinxin Yin
1, 2, 3, 4
,
Xin Pan
1, 2, 3, 4
,
Jingyu Zhang
1, 2, 3, 4
,
Xinhui Fan
1, 2, 3, 4
,
Jiaxin Li
1, 2, 3, 4
,
Xiaoxuan Zhai
1, 2, 3, 4
,
Lijun Jiang
1, 2, 3, 4
,
Panpan Hao
4
,
Jiali Wang
1, 2, 3, 4
,
Yuguo Chen
1, 2, 3, 4
1
Department of Emergency and Chest Pain Center, China
|
2
Clinical Research Center for Emergency and Critical Care Medicine of Shandong Province, China
|
3
Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, China
|
4
Key Laboratory of Cardiovascular Remodeling and Function Research, China
|
Publication type: Journal Article
Publication date: 2023-03-28
scimago Q1
wos Q1
SJR: 1.220
CiteScore: 8.9
Impact factor: 4.8
ISSN: 16639812
PubMed ID:
37056987
Pharmacology
Pharmacology (medical)
Abstract
Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and extracellular matrix collagen deposition are the hallmarks of cardiac fibrosis, which are modulated by multiple signaling pathways and various types of cells in time-dependent manners. Our understanding of the development of cardiac fibrosis after MI has evolved in basic and clinical researches, and the regulation of fibrotic remodeling may facilitate novel diagnostic and therapeutic strategies, and finally improve outcomes. Here, we aim to elaborate pathophysiology, examination and intervention of cardiac fibrosis after MI.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
International Journal of Molecular Sciences
3 publications, 6%
|
|
|
BMC Cardiovascular Disorders
2 publications, 4%
|
|
|
Frontiers in Pharmacology
2 publications, 4%
|
|
|
International Immunopharmacology
2 publications, 4%
|
|
|
International Journal of Nanomedicine
2 publications, 4%
|
|
|
BMC Medical Imaging
1 publication, 2%
|
|
|
Phytomedicine
1 publication, 2%
|
|
|
Redox Biology
1 publication, 2%
|
|
|
Current Issues in Molecular Biology
1 publication, 2%
|
|
|
Oxidative Medicine and Cellular Longevity
1 publication, 2%
|
|
|
Applied Biochemistry and Biotechnology
1 publication, 2%
|
|
|
Current Pharmaceutical Design
1 publication, 2%
|
|
|
The Siberian Journal of Clinical and Experimental Medicine
1 publication, 2%
|
|
|
Saudi Pharmaceutical Journal
1 publication, 2%
|
|
|
Life Sciences
1 publication, 2%
|
|
|
Cell Proliferation
1 publication, 2%
|
|
|
Toxicology Research
1 publication, 2%
|
|
|
Journal of Molecular and Cellular Cardiology
1 publication, 2%
|
|
|
European Journal of Pharmacology
1 publication, 2%
|
|
|
Free Radical Biology and Medicine
1 publication, 2%
|
|
|
Materials Today Bio
1 publication, 2%
|
|
|
Biomedicines
1 publication, 2%
|
|
|
Cardiovascular Research
1 publication, 2%
|
|
|
Expert Reviews in Molecular Medicine
1 publication, 2%
|
|
|
Echocardiography
1 publication, 2%
|
|
|
Apoptosis : an international journal on programmed cell death
1 publication, 2%
|
|
|
ACS Nano
1 publication, 2%
|
|
|
Cell Biology and Toxicology
1 publication, 2%
|
|
|
Journal of Inflammation Research
1 publication, 2%
|
|
|
American Journal of Physiology - Cell Physiology
1 publication, 2%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 30%
|
|
|
Springer Nature
9 publications, 18%
|
|
|
MDPI
5 publications, 10%
|
|
|
Wiley
5 publications, 10%
|
|
|
Taylor & Francis
3 publications, 6%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 4%
|
|
|
Frontiers Media S.A.
2 publications, 4%
|
|
|
Oxford University Press
2 publications, 4%
|
|
|
Cardiology Research Institute
1 publication, 2%
|
|
|
Cambridge University Press
1 publication, 2%
|
|
|
American Chemical Society (ACS)
1 publication, 2%
|
|
|
American Physiological Society
1 publication, 2%
|
|
|
SAGE
1 publication, 2%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2%
|
|
|
IMR Press
1 publication, 2%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
51
Total citations:
51
Citations from 2024:
49
(98%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Yin X. et al. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention // Frontiers in Pharmacology. 2023. Vol. 14.
GOST all authors (up to 50)
Copy
Yin X., Yin X., Pan X., Zhang J., Fan X., Li J., Zhai X., Jiang L., Hao P., Wang J., Chen Y. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention // Frontiers in Pharmacology. 2023. Vol. 14.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3389/fphar.2023.1070973
UR - https://doi.org/10.3389/fphar.2023.1070973
TI - Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
T2 - Frontiers in Pharmacology
AU - Yin, Xiaoying
AU - Yin, Xinxin
AU - Pan, Xin
AU - Zhang, Jingyu
AU - Fan, Xinhui
AU - Li, Jiaxin
AU - Zhai, Xiaoxuan
AU - Jiang, Lijun
AU - Hao, Panpan
AU - Wang, Jiali
AU - Chen, Yuguo
PY - 2023
DA - 2023/03/28
PB - Frontiers Media S.A.
VL - 14
PMID - 37056987
SN - 1663-9812
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Yin,
author = {Xiaoying Yin and Xinxin Yin and Xin Pan and Jingyu Zhang and Xinhui Fan and Jiaxin Li and Xiaoxuan Zhai and Lijun Jiang and Panpan Hao and Jiali Wang and Yuguo Chen},
title = {Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
publisher = {Frontiers Media S.A.},
month = {mar},
url = {https://doi.org/10.3389/fphar.2023.1070973},
doi = {10.3389/fphar.2023.1070973}
}